142 related articles for article (PubMed ID: 36125714)
1. In Vitro Assay System to Detect Drug-Induced Bile Acid-Dependent Cytotoxicity Using Hepatocytes.
Takemura A; Ito K
Methods Mol Biol; 2022; 2544():119-127. PubMed ID: 36125714
[TBL] [Abstract][Full Text] [Related]
2. In vitro bile acid-dependent hepatocyte toxicity assay system using human induced pluripotent stem cell-derived hepatocytes: Current status and disadvantages to overcome.
Sakai Y; Iwao T; Susukida T; Nukaga T; Takemura A; Sekine S; Ito K; Matsunaga T
Drug Metab Pharmacokinet; 2019 Aug; 34(4):264-271. PubMed ID: 31285099
[TBL] [Abstract][Full Text] [Related]
3. The C-DILI™ Assay: An Integrated In Vitro Approach to Predict Cholestatic Hepatotoxicity.
Jackson JP; Brouwer KR
Methods Mol Biol; 2019; 1981():75-85. PubMed ID: 31016648
[TBL] [Abstract][Full Text] [Related]
4. Detection of Drug-Induced Cholestasis Potential in Sandwich-Cultured Human Hepatocytes.
Deferm N; Richert L; Van Brantegem P; De Vocht T; Qi B; de Witte P; Bouillon T; Annaert P
Methods Mol Biol; 2019; 1981():335-350. PubMed ID: 31016665
[TBL] [Abstract][Full Text] [Related]
5. Prediction of the Clinical Risk of Drug-Induced Cholestatic Liver Injury Using an In Vitro Sandwich Cultured Hepatocyte Assay.
Susukida T; Sekine S; Nozaki M; Tokizono M; Ito K
Drug Metab Dispos; 2015 Nov; 43(11):1760-8. PubMed ID: 26329788
[TBL] [Abstract][Full Text] [Related]
6. Basal efflux of bile acids contributes to drug-induced bile acid-dependent hepatocyte toxicity in rat sandwich-cultured hepatocytes.
Susukida T; Sekine S; Ogimura E; Aoki S; Oizumi K; Horie T; Ito K
Toxicol In Vitro; 2015 Oct; 29(7):1454-63. PubMed ID: 26055650
[TBL] [Abstract][Full Text] [Related]
7. Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.
Ogimura E; Sekine S; Horie T
Biochem Biophys Res Commun; 2011 Dec; 416(3-4):313-7. PubMed ID: 22108051
[TBL] [Abstract][Full Text] [Related]
8. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: A review.
Cheng Y; Woolf TF; Gan J; He K
Chem Biol Interact; 2016 Aug; 255():23-30. PubMed ID: 26683212
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bile salt transport by drugs associated with liver injury in primary hepatocytes from human, monkey, dog, rat, and mouse.
Zhang J; He K; Cai L; Chen YC; Yang Y; Shi Q; Woolf TF; Ge W; Guo L; Borlak J; Tong W
Chem Biol Interact; 2016 Aug; 255():45-54. PubMed ID: 27000539
[TBL] [Abstract][Full Text] [Related]
10. Metabolic Activation of Cholestatic Drug-Induced Bile Acid-Dependent Toxicity in Human Sandwich-Cultured Hepatocytes.
Ogimura E; Tokizono M; Sekine S; Nakagawa T; Bando K; Ito K
J Pharm Sci; 2017 Sep; 106(9):2509-2514. PubMed ID: 28465153
[TBL] [Abstract][Full Text] [Related]
11. An in vitro assay to assess transporter-based cholestatic hepatotoxicity using sandwich-cultured rat hepatocytes.
Ansede JH; Smith WR; Perry CH; St Claire RL; Brouwer KR
Drug Metab Dispos; 2010 Feb; 38(2):276-80. PubMed ID: 19910518
[TBL] [Abstract][Full Text] [Related]
12. Predictive Value of Cellular Accumulation of Hydrophobic Bile Acids As a Marker of Cholestatic Drug Potential.
Burban A; Sharanek A; Humbert L; Eguether T; Guguen-Guillouzo C; Rainteau D; Guillouzo A
Toxicol Sci; 2019 Apr; 168(2):474-485. PubMed ID: 30629237
[TBL] [Abstract][Full Text] [Related]
13. Organic solute transporter OSTα/β is overexpressed in nonalcoholic steatohepatitis and modulated by drugs associated with liver injury.
Malinen MM; Ali I; Bezençon J; Beaudoin JJ; Brouwer KLR
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G597-G609. PubMed ID: 29420067
[TBL] [Abstract][Full Text] [Related]
14. Model Systems for Studying the Role of Canalicular Efflux Transporters in Drug-Induced Cholestatic Liver Disease.
Stieger B; Mahdi ZM
J Pharm Sci; 2017 Sep; 106(9):2295-2301. PubMed ID: 28385542
[TBL] [Abstract][Full Text] [Related]
15. Establishment of a Drug-Induced, Bile Acid-Dependent Hepatotoxicity Model Using HepaRG Cells.
Susukida T; Sekine S; Nozaki M; Tokizono M; Oizumi K; Horie T; Ito K
J Pharm Sci; 2016 Apr; 105(4):1550-60. PubMed ID: 26952880
[TBL] [Abstract][Full Text] [Related]
16. Nimesulide and 4'-Hydroxynimesulide as Bile Acid Transporters Inhibitors Are Contributory Factors for Drug-Induced Cholestasis.
Zhou L; Pang X; Jiang J; Zhong D; Chen X
Drug Metab Dispos; 2017 May; 45(5):441-448. PubMed ID: 28202577
[TBL] [Abstract][Full Text] [Related]
17. Critical Factors in the Assessment of Cholestatic Liver Injury In Vitro.
Woolbright BL; Jaeschke H
Methods Mol Biol; 2015; 1250():363-76. PubMed ID: 26272158
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for development of cholestatic drug-induced liver injury: inhibition of hepatic basolateral bile acid transporters multidrug resistance-associated proteins 3 and 4.
Köck K; Ferslew BC; Netterberg I; Yang K; Urban TJ; Swaan PW; Stewart PW; Brouwer KL
Drug Metab Dispos; 2014 Apr; 42(4):665-74. PubMed ID: 24154606
[TBL] [Abstract][Full Text] [Related]
19. A novel differentiated HuH-7 cell model to examine bile acid metabolism, transport and cholestatic hepatotoxicity.
Saran C; Fu D; Ho H; Klein A; Fallon JK; Honkakoski P; Brouwer KLR
Sci Rep; 2022 Aug; 12(1):14333. PubMed ID: 35995956
[TBL] [Abstract][Full Text] [Related]
20. Drug-induced perturbations of the bile acid pool, cholestasis, and hepatotoxicity: mechanistic considerations beyond the direct inhibition of the bile salt export pump.
Rodrigues AD; Lai Y; Cvijic ME; Elkin LL; Zvyaga T; Soars MG
Drug Metab Dispos; 2014 Apr; 42(4):566-74. PubMed ID: 24115749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
